Press release Read more about Hybrigenics’ compound inhibits Ubiqitin-Specific Protease 10 (USP10) and shows activity in preclinical models of Acute Myeloid Leukemia (AML)
Press release Read more about DELFINGEN expands its global presence with the construction of a new site in Nicaragua
Press release Read more about AP Alternative Assets to Release Third Quarter Financial Results on November 1, 2017
Press release Read more about Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017